IN8bio, Inc. - Common Stock — 분기별 현금 흐름 (NASDAQ:INAB) | MetaTrader

전체 차트 열기 Full chart

Financials

개요 성명 통계

총자산 20.94 M19.87 M19.37 M16.77 M32.28 M26.27 M 총 부채 6.47 M5.99 M4.13 M3.58 M4.72 M3.48 M 자본금 총액 14.48 M13.88 M15.24 M13.19 M27.56 M22.78 M 총 부채 및 주주자본 20.94 M19.87 M19.37 M16.77 M32.28 M26.27 M 총부채 —————— 순부채 ——————

뉴스

H.C. 웨인라이트, IN8bio 투자의견 ’매수’ 유지…재무 건전성 뒷받침

H.C. Wainwright reiterates IN8bio stock rating on financing strength

IN8bio, Kate Rochlin 사장 임명, COO 역할 겸직

IN8bio appoints Kate Rochlin as president while retaining COO role

IN8bio promotes Kate Rochlin to president and chief operating officer

IN8bio, 암 치료 위한 4020만 달러 규모의 사모 자금 조달

IN8bio secures up to $40.2 million in private placement for cancer therapy

미즈호, IN8bio 목표 주가 하향…자금 조달 우려

Mizuho lowers IN8bio stock price target on financing concerns

IN8bio Recognizes Achievement of 4-Years in Remission for Patient Treated with INB-200 in Glioblastoma Trial

INB-200 shows promise in glioblastoma trial

IN8bio reports promising lupus treatment data